Cerebral Venous Thrombosis in Behçet's Disease

Arthritis Care and Research

Volumn 61, Issue 4, 2009, Pages 518-526

  Saadoun, D ^a   Wechsler, B ^a   Resche Rigon, M ^b   Trad, S ^a   Le Thi Huong, D ^a   Sbai, A ^a   Dormont, D ^a   Amoura, Z ^a   Cacoub, P ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; PREDNISONE; STEROID;

ADULT; ARTICLE; BEHCET DISEASE; CARDIOVASCULAR RISK; CEREBRAL VEIN THROMBOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; ILIOPSOAS HEMATOMA; LEG HEMATOMA; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE ATROPHY; PAPILLEDEMA; PROGNOSIS; RELAPSE; SUBDURAL HEMATOMA; VEIN THROMBOSIS; VISUAL IMPAIRMENT;

ADULT; ANTICOAGULANTS; BEHCET SYNDROME; COHORT STUDIES; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 65249100145     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24393     Document Type: Article

References (38)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
2. Yazici H, Yurdakul S, Hamuryudan V. Behçet's disease. Curr Opin Rheumatol 2001;13:18-22.
3. Siva A, Altintas A, Saip S. Behçet's syndrome and the nervous system. Curr Opin Neurol 2004;17:347-57.
4. Serdaroglu P, Yazici H, Ozdemir C, Yurdakul S, Bahar S, Aktin E. Neurologic involvement in Behçet's syndrome: a prospective study. Arch Neurol 1989;46:265-9.
5. Rougemont D, Bousser MG, Wechsler B, Bletry O, Castaigne P, Godeau P. Neurologic manifestations of Behçet's disease: 24 cases. Rev Neurol (Paris) 1982;138:493-505. In French.
6. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16:790-5.
7. Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet's syndrome. Brain 1999;122:2183-94.
8. Akman-Demir G, Serdaroglu P, Tasci B, and the Neuro- Behçet's Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999;122:2171-82.
9. Ramos C, Sa G, Tedim Cruz V, Lopes A, Xavier J, Cruz R. Neuro-Behçet: MR study of a group of patients. Acta Med Port 2006;19:494-8. In Portugese.
10. Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2006;3:148-55.
11. Erdem H, Dinc A, Pay S, Simsek I, Uysal Y. A neuro-Behçet's case complicated with intracranial hypertension successfully treated by a lumboperitoneal shunt. Joint Bone Spine 2006; 73:200-1.
12. Farah S, Al-Shubaili A, Montaser A, Hussein JM, Malaviya AN, Mukhtar M, et al. Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry 1998;64:382-4.
13. Wechsler B, Vidailhet M, Piette JC, Bousser MG, Dell Isola B, Bletry O, et al. Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases. Neurology 1992;42:614-8.
14. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
15. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis: a review of 38 cases. Stroke 1985;16:199-213.
16. Le Cessie S, van Houwelingen HC. Testing the fit of a regression model via score tests in random effects models. Biometrics 1995;51:600-14.
17. Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 1995;51:1469-82.
18. Berlin C. Behçet's syndrome with involvement of central nervous system. Arch Derm Syph 1944;49:227-33.
19. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103.
20. Houman MH, Hamzaoui-B'Chir S, Ben Ghorbel I, Lamloum M, Ben Ahmed M, Abdelhak S, et al. Neurologic manifestations of Behçet's disease: analysis of a series of 27 patients. Rev Med Interne 2002;23:592-606. In French.
21. Al-Araji A, Sharquie K, Al-Rawi Z. Prevalence and patterns of neurological involvement in Behçet's disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 2003;74:608- 13.
22. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behçet's disease. Ann Rheum Dis 2008;67:1656-62.
23. Yazici H, Yurdakul S, Hamuryudan V. The management of Behçet's syndrome: how are we doing? Clin Exp Rheumatol 1999;17:145-7.
24. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. Management of Behçet's disease: a systematic literature review for the EULAR evidence based recommendations for the management of Behçet's disease. Ann Rheum Dis 2008. E-pub ahead of print.
25. Canhao P, Cortesao A, Cabral M, Ferro JM, Stam J, Bousser MG, et al. Are steroids useful to treat cerebral venous thrombosis? Stroke 2008;39:105-10.
26. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70.
27. Chiras J, Bousser MG, Meder JF, Koussa A, Bories J. CT in cerebral thrombophlebitis. Neuroradiology 1985;27:145-54.
28. Teh LS, O'Connor GM, O'Sullivan MM, Pandit JC, Beck L, Williams BD. Recurrent papilloedema and early onset optic atrophy in Behçet's syndrome. Ann Rheum Dis 1990;49: 410-1.
29. Pamir MN, Kansu T, Erbengi A, Zileli T. Papilledema in Behçet's syndrome. Arch Neurol 1981;38:643-5.
30. Gosk-Bierska I, Wysokinski W, Brown RD Jr, Karnicki K, Grill D, Wiste H, et al. Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival. Neurology 2006;67:814-9.
31. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984;43:783-9.
32. Matsumoto T, Uekusa T, Fukuda Y. Vasculo-Behçet's disease: a pathologic study of eight cases. Hum Pathol 1991;22:45-51.
33. Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A. Disease patterns of patients with Behçet's disease demonstrated by factor analysis. Clin Exp Rheumatol 1999;17:347- 50.
34. Tunc R, Saip S, Siva A, Yazici H. Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 2004;63:1693-4.
35. Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, et al. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum 2004;51:177-83.
36. Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997;28:2363-9.
37. Wolf SM, Schotland DL, Phillips LL. Involvement of nervous system in Behçet's syndrome. Arch Neurol 1965;12:315-25.
38. Yazici H, Basaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, et al. The ten-year mortality in Behçet's syndrome. Br J Rheumatol 1996;35:139-41.